Concepedia
Statistics
Publications
14
Citations
667
H-Index
12
Active since
2014
Affiliations
Bayer (Norway)(Current)
657 Oslo
Bayer (Germany)
University of Wuppertal
Jenny Karlsson is an author at Bayer (Norway) specializing in targeted therapy, oncology, and targeted cancer therapy.
Publications per year
2014–2024
Preclinical Efficacy of a PSMA-Targeted Thorium-227 Conjugate (PSMA-TTC), a Targeted Alpha Therapy for Prostate Cancer
Stefanie Hammer, Urs B. Hagemann, Sabine Zitzmann-Kolbe et al. · Clinical Cancer Research · 2019 · 121 citations · Full text
Medicine, Oncology, Pharmacology +17
Mesothelin-Targeted Thorium-227 Conjugate (MSLN-TTC): Preclinical Evaluation of a New Targeted Alpha Therapy for Mesothelin-Positive Cancers
Urs B. Hagemann, Christine Ellingsen, Joachim Schuhmacher et al. · Clinical Cancer Research · 2019 · 108 citations
<i>In Vitro</i> and <i>In Vivo</i> Efficacy of a Novel CD33-Targeted Thorium-227 Conjugate for the Treatment of Acute Myeloid Leukemia
Urs B. Hagemann, Katrine Wickstroem, Ellen Wang et al. · Molecular Cancer Therapeutics · 2016 · 80 citations
Hindering and buffering factors for parental sleep in neonatal care. A phenomenographic study
Ulla Edéll‐Gustafsson, Charlotte Angelhoff, Ewa Johnsson et al. · Journal of Clinical Nursing · 2014 · 57 citations · Full text
Nursing, Pediatrics, Infant Health +11
Immunostimulatory effects of targeted thorium-227 conjugates as single agent and in combination with anti-PD-L1 therapy
Pascale Lejeune, Véronique Cruciani, Axel Berg‐Larsen et al. · Journal for ImmunoTherapy of Cancer · 2021 · 52 citations · Full text
Life Sciences, Immunology, Oncology +17
1–5 of 14